ADD and or ADHD
This new study revealed that stimulant medications, specifically methylphenidate, are associated with a 6- to 7-times increased risk for sudden death in children and adolescents. UGH!
What does the FDA say about that? “Given the limitation of this study’s methodology, the FDA is unable to conclude that these data affect the overall risk and benefit profile of stimulant medications used to treat attention-deficit/hyperactivity.”